The FDA has approved Cysview (hexaminolevulinate HCl, from GE Healthcare), an optical imaging agent, for use in the cystoscopic detection of non-muscle-invasive papillary cancer of the bladder among ...

Dr. Yair Lotan, UTSW, presented on BLC with Cysview for surveillance Dr. Yair Lotan M.D., Professor of Urology, UT Southwestern Medical Center and the lead author on a new Consensus paper for use of ...

Photocure ASA, the bladder cancer company, announces the start of its Cysview sales, marketing and distribution operations in the Canadian market. In August 2021 Photocure had reached an agreement ...

CLEVELAND, Ohio -- In 2010, according to the National Cancer Institute, an estimated 70,000 people in the United States were diagnosed with bladder cancer. An estimated 15,000 people died from the ...

FOX CHASE (WPVI) -- Bladder cancer is one of the most common cancers - just behind melanoma. Yet, many people don't know much about it. Doctors are now using a diagnostic tool to better find and ...

Doctors have a new way of detecting tiny bladder cancer tumors by making them glow. New technology called Cysview uses a combination of dye and fluorescent light to show surgeons small cancerous ...

Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 135.1 million in the fourth quarter of 2025 (Q4 2024: NOK 128.6 million), and a commercial EBITDA of NOK 8.4 million (Q4 2024: ...

OSLO, Norway, Nov. 5, 2019 /PRNewswire/ -- Photocure ASA., (OSE: PHO), The United States Centers for Medicare and Medicaid Services (CMS) has released its Final Rule maintaining the reimbursement code ...

(RTTNews) - Photocure ASA (PHCUF.PK), a Norwegian specialty pharma company, said on Monday that it has started sales, marketing, and distribution operations of Cysview in Canada. Cysview is an optical ...

(StatePoint) When Cameron Todd was diagnosed with prostate cancer in 2017, he never imagined that just two and a half months later, his doctors would diagnose him with bladder cancer. Concerned about ...

FOX CHASE, Pa. -- Bladder cancer is one of the most common cancers - just behind melanoma. Yet, many people don't know much about it. Doctors are now using a diagnostic tool to better find and ...

June 4, 2010 — The US Food and Drug Administration (FDA) has approved hexaminolevulinate HCl (Cysview; GE Healthcare, under license from Photocure ASA) for the detection of non-muscle-invasive ...